p300 in Prostate Cancer Proliferation and Progression

Cancer Research

Volumn 63, Issue 22, 2003, Pages 7638-7640

  Debes, Jose D ^a   Sebo, Thomas J ^b   Lohse, Christine M ^b   Murphy, Linda M ^b   Haugen, De Anna L ^b   Tindall, Donald J ^a,b  

^a DEPARTMENT OF UROLOGY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; INTERLEUKIN 6; PROTEIN; PROTEIN MIB I; PROTEIN P300; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL DISRUPTION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROTEIN EXPRESSION; TRANSACTIVATION; TUMOR VOLUME;

ACETYLTRANSFERASES; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; DISEASE PROGRESSION; HISTONE ACETYLTRANSFERASES; HUMANS; KI-67 ANTIGEN; MALE; PLOIDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0345275876     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Grossmann, M. E., Huang, H., and Tindall, D. J. Androgen receptor signaling in androgen-refractory prostate cancer. J. Natl. Cancer Inst., 93: 1687-1697, 2001.
2. Debes, J. D., and Tindall, D. J. The role of androgens and the androgen receptor in prostate cancer. Cancer Lett., 187: 1-7, 2002.
3. Li, P., Yu, X., Ge, K., Melamed, J., Roeder, R. G., and Wang, Z. Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer. Am. J. Pathol., 161: 1467-1474, 2002.
4. Comuzzi, B., Lambrinidis, L., Rogatsch, H., Godoy-Tundidor, S., Knezevic, N., Krhen, I., Marekovic, Z., Bartsch, G., Klocker, H., Hobisch, A., and Culig, Z. The transcriptional co-activator cAMP response element-binding protein-binding protein is expressed in prostate cancer and enhances androgen- and anti-androgen-induced androgen receptor function. Am. J. Pathol., 162: 233-241, 2003.
5. Tanra, A. J., Shinno, H., Kugaya, A., Muraoka, M., Oyamada, T., Uchitomi, Y., and Yamawaki, S. p300 gene alterations in colorectal and gastric carcinomas. J. Neural Trans., 103: 69-75, 1996.
6. Fan, S., Ma, Y. X., Wang, C., Yuan, R. Q., Meng, Q., Wang, J. A., Erdos, M., Goldberg, I. D., Webb, P., Kushner, P. J., Pestell, R. G., and Rosen, E. M. p300 Modulates the BRCA1 inhibition of estrogen receptor activity. Cancer Res., 62: 141-151, 2002.
7. Bandyopadhyay, D., Okan, N. A., Bales, E., Nascimento, L., Cole, P. A., and Medrano, E. E. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes. Cancer Res., 62: 6231-6239, 2002.
8. Debes, J. D., Schmidt, L. J., Huang, H., and Tindall, D. J. P300 mediates androgen-independent transactivation of the androgen receptor by interleukin 6. Cancer Res., 62: 5632-5636, 2002.
9. Bash, T., Fu, M., Galbiati, F., Albanese, C., Sage, D. R., Schlegel, A., Zhurinsky, J., Shtutman, M., Ben-Ze'ev, A., Lisanti, M. P., and Pestell, R. G. p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation, J. Biol. Chem., 275: 21203-9, 2000.
10. Sebo, T. J., Cheville, J. C., Riehle, D. L., Lohse, C. M., Pankratz, V. S., Myers, R. P., Blute, M. L., and Zincke, H. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion. Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases. Cancer, 91: 2196-204, 2001.
11. Sebo, T. J., Cheville, J. C., Riehle. D. L., Lohse, C. M., Pankratz, V. S., Myers, R. P., Blute, M. L., and Zincke, H. Perineural invasion and MIB-I positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer. Am. J. Surg. Pathol., 26: 431-439, 2002.
12. Cheville, J. C., Tindall, D., Boelter, C., Jenkins, R., Lohse, C. M., Pankratz, V. S., Sebo, T. J., Davis, B., and Blute, M. L. Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival. Cancer (Phila.). 95: 1028-1036, 2002.
13. Magenta, A., Cenciarelli, C., De Santa, F., Fuschi, P., Martelli, F., Caruso, M., and Felsani, A. MyoD stimulates RB promoter activity via the CREB/p300 nuclear transduction pathway. Mol. Cell. Biol., 23: 2893-906, 2003.
14. Wasner, M., Tschop, K., Spiesbach, K., Haugwitz, U., Johne, C., Mossner, J., Mantovani, R., and Engeland, K. Cyclin B1 transcription is enhanced by the p300 coactivator and regulated during the cell cycle by a CHR-dependent repression mechanism. FEBS Lett., 536: 66-70, 2003.